Order of the Court (Eighth Chamber) of 14 November 2013.   Astrazeneca AB v Comptroller General of Patents; Designs and Trade Marks.   Reference for a preliminary ruling: High Court of Justice (England &amp; Wales); Chancery Division (Patents Court) - United Kingdom.   Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Article 13(1) - Concept of ‘first authorisation to place [a product] on the market in the Community’ - Authorisation issued by the Swiss Institute for Medicinal Products (Swissmedic) - Automatic recognition in Liechtenstein - Authorisation issued by the European Medicines Agency - Period of validity of a certificate. 